These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10444273)

  • 1. Encapsulation in hollow fibres of xenogeneic cells engineered to secrete IL-4 or IL-13 ameliorates murine collagen-induced arthritis (CIA).
    Bessis N; Honiger J; Damotte D; Minty A; Fournier C; Fradelizi D; Boissier M
    Clin Exp Immunol; 1999 Aug; 117(2):376-82. PubMed ID: 10444273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Syngeneic fibroblasts transfected with a plasmid encoding interleukin-4 as non-viral vectors for anti-inflammatory gene therapy in collagen-induced arthritis.
    Bessis N; Cottard V; Saidenberg-Kermanach N; Lemeiter D; Fournier C; Boissier MC
    J Gene Med; 2002; 4(3):300-7. PubMed ID: 12112647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of collagen-induced arthritis in mice by treatment with vector cells engineered to secrete interleukin-13.
    Bessis N; Boissier MC; Ferrara P; Blankenstein T; Fradelizi D; Fournier C
    Eur J Immunol; 1996 Oct; 26(10):2399-403. PubMed ID: 8898952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engraftment of cutaneous fibroblasts within synovial membrane in a nonhuman primate: short-term results.
    Bessis N; Lemeiter D; Laroche L; Fournier C; Huizinga T; Brok H; 't Hart B; Boissier MC
    Joint Bone Spine; 2007 Jan; 74(1):48-51. PubMed ID: 17224293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of proinflammatory cytokine production in tumour necrosis factor-alpha (TNF-alpha)-transgenic mice by treatment with cells engineered to secrete IL-4, IL-10 or IL-13.
    Bessis N; Chiocchia G; Kollias G; Minty A; Fournier C; Fradelizi D; Boissier MC
    Clin Exp Immunol; 1998 Feb; 111(2):391-6. PubMed ID: 9486409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Fas ligand improves the effect of IL-4 in collagen-induced arthritis.
    Guéry L; Batteux F; Bessis N; Breban M; Boissier MC; Fournier C; Chiocchia G
    Eur J Immunol; 2000 Jan; 30(1):308-15. PubMed ID: 10602054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of diabetes in non-obese diabetic mice by xenografts of porcine islets entrapped in hollow fibres composed of polyacrylonitrile-sodium methallylsulphonate copolymer.
    Rivereau AS; Darquy S; Chaillous L; Maugendre S; Gouin E; Reach G; Sai P
    Diabetes Metab; 1997 Jun; 23(3):205-12. PubMed ID: 9233997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental gene therapy of cancer using tumor cells engineered to secrete interleukin-13.
    Lebel-Binay S; Laguerre B; Quintin-Colonna F; Conjeaud H; Magazin M; Miloux B; Pecceu F; Caput D; Ferrara P; Fradelizi D
    Eur J Immunol; 1995 Aug; 25(8):2340-8. PubMed ID: 7664796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.
    Zhang H; Zhu SJ; Wang W; Wei YJ; Hu SS
    Gene Ther; 2008 Jan; 15(1):40-8. PubMed ID: 17943144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen II-pulsed antigen-presenting cells genetically modified to secrete IL-4 down-regulate collagen-induced arthritis.
    Guéry L; Chiocchia G; Batteux F; Boissier MC; Fournier C
    Gene Ther; 2001 Dec; 8(24):1855-62. PubMed ID: 11821939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis.
    Mauri C; Williams RO; Walmsley M; Feldmann M
    Eur J Immunol; 1996 Jul; 26(7):1511-8. PubMed ID: 8766554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of IL-18 binding protein and IL-4 regulates Th1/Th2 cytokine response in murine collagen-induced arthritis.
    Leng J; Yao H; Shen J; Wang K; Zhuo G; Wang Z
    Acta Biochim Biophys Sin (Shanghai); 2008 Feb; 40(2):116-24. PubMed ID: 18235973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmid encoding interleukin-4 in the amelioration of murine collagen-induced arthritis.
    Kageyama Y; Koide Y; Uchijima M; Nagata T; Yoshida A; Taiki A; Miura T; Nagafusa T; Nagano A
    Arthritis Rheum; 2004 Mar; 50(3):968-75. PubMed ID: 15022341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual role of IL-12 in early and late stages of murine collagen type II arthritis.
    Joosten LA; Lubberts E; Helsen MM; van den Berg WB
    J Immunol; 1997 Oct; 159(8):4094-102. PubMed ID: 9379000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the soluble form of the interleukin-1 receptor accessory protein as an inhibitor of interleukin-1 in collagen-induced arthritis.
    Smeets RL; van de Loo FA; Joosten LA; Arntz OJ; Bennink MB; Loesberg WA; Dmitriev IP; Curiel DT; Martin MU; van den Berg WB
    Arthritis Rheum; 2003 Oct; 48(10):2949-58. PubMed ID: 14558102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 secretion increases signal persistence of HEMA-MMA-microencapsulated luciferase-modified CHO fibroblasts in mice.
    Surzyn M; Symes J; Medin JA; Sefton MV
    Tissue Eng Part A; 2009 Jan; 15(1):127-36. PubMed ID: 18710337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against collagen-induced arthritis by electrotransfer of an expression plasmid for the interleukin-4.
    Ho SH; Hahn W; Lee HJ; Kim DS; Jeong JG; Kim S; Yu SS; Jeon ES; Kim S; Kim JM
    Biochem Biophys Res Commun; 2004 Sep; 321(4):759-66. PubMed ID: 15358092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of interleukin-10 gene electrotransfer into skeletal muscle in mice with collagen-induced arthritis.
    Saidenberg-Kermanac'h N; Bessis N; Deleuze V; Bloquel C; Bureau M; Scherman D; Boissier MC
    J Gene Med; 2003 Feb; 5(2):164-71. PubMed ID: 12539154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion.
    Lubberts E; Koenders MI; Oppers-Walgreen B; van den Bersselaar L; Coenen-de Roo CJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2004 Feb; 50(2):650-9. PubMed ID: 14872510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.